Rev. Jesse Jackson in hospital for PSP observation
Civil rights leader Reverend Jesse Jackson, 84, is under hospital observation in Chicago for Progressive Supranuclear Palsy. Send your prayers for the revered activist.
Civil rights leader Reverend Jesse Jackson, 84, is under hospital observation in Chicago for Progressive Supranuclear Palsy. Send your prayers for the revered activist.
Civil rights leader Rev. Jesse Jackson, 84, has been hospitalised in Chicago for observation related to Progressive Supranuclear Palsy. Read the latest updates on his condition.
Scientists discover that tiny antibodies from llamas could neutralise toxic proteins linked to Alzheimer's disease, offering new hope for treatment development.
Groundbreaking research reveals prolonged exposure to loud noise may significantly increase Parkinson's disease risk. Discover the science behind this hidden health threat.
Exclusive look at the UK's pioneering Deep Dementia Phenotyping Laboratory where cutting-edge technology meets compassionate care to transform Alzheimer's treatment
Groundbreaking research reveals three major pathways causing ALS, offering new hope for targeted therapies that could slow or stop the devastating neurodegenerative disease's progression.
Groundbreaking research reveals how retinal scans could revolutionise early Alzheimer's detection, offering hope for millions through non-invasive testing years before symptoms appear.
Revolutionary research uncovers how the brain's cleaning process during sleep could dramatically reduce dementia risk - and how to enhance it naturally.
Former England captain Lewis Moody makes heartfelt appeal to rugby icon Martin Johnson after devastating Motor Neurone Disease diagnosis, sparking urgent calls for research funding.
University of Strathclyde researchers develop groundbreaking infrared laser technique that could detect Alzheimer's disease years before symptoms appear, offering new hope for early intervention.
University of Strathclyde researchers discover revolutionary laser technology that could detect Alzheimer's disease years before symptoms appear, offering new hope for early intervention.
Former England rugby captain Lewis Moody shares heartbreaking Motor Neurone Disease diagnosis while thanking fans for overwhelming support in moving social media statement.
Groundbreaking research reveals a previously unknown gene variant that dramatically increases Alzheimer's risk, offering new hope for early detection and treatment strategies.
Groundbreaking research reveals the complex interplay of genetic susceptibility, environmental triggers, and lifestyle factors that contribute to motor neurone disease risk, as rugby legend Lewis Moody shares his diagnosis journey.
Shocking new research reveals former rugby players are 15 times more likely to develop Motor Neurone Disease, prompting urgent calls for safety reforms in the sport.
Former England rugby captain Lewis Moody MBE announces he's been diagnosed with motor neurone disease, vowing to fight the condition with same determination he showed on the pitch.
Former England captain Lewis Moody opens up about his motor neurone disease diagnosis, sharing his determination to fight the condition and raise awareness for research.
Former England rugby captain Lewis Moody MBE shares emotional MND diagnosis, joining fellow rugby stars in motor neurone disease battle while vowing to fight with characteristic courage.
Groundbreaking Cambridge research reveals how the brain's 'recycling system' fails in Alzheimer's, opening doors to revolutionary new treatments that could slow or prevent the devastating disease.
Groundbreaking UK research suggests simple smell tests could identify neurodegenerative diseases like Alzheimer's and Parkinson's up to a decade before traditional symptoms appear, revolutionising early diagnosis.
Groundbreaking research reveals that losing your sense of smell may be one of the earliest warning signs for neurodegenerative diseases like Alzheimer's and Parkinson's, potentially enabling earlier intervention and treatment.
Groundbreaking research reveals Parkinson's disease may originate in the gut years before brain symptoms appear, opening new possibilities for early intervention and treatment.
Revolutionary Cambridge study reveals how rogue PINK1 protein acts as 'master switch' for Parkinson's, opening new pathways for treatments that could slow or prevent disease progression.
Groundbreaking research reveals how artificial intelligence can detect Parkinson's disease through gut bacteria analysis up to seven years before diagnosis, revolutionising early detection.
Groundbreaking research is revolutionising dementia care with new treatments that tackle underlying disease processes rather than just managing symptoms. Discover the promising developments bringing hope to millions.
Cambridge researchers identify how brain inflammation drives dementia progression and reveal promising drug candidates that could slow or prevent cognitive decline.
In a landmark move for brain health in football, the Alzheimer's Society becomes the official charity partner for England, Wales, and grassroots football, tackling the sport's dementia crisis head-on.
The Football Association partners with Alzheimer's Society to support dementia sufferers, inspired by a devoted fan's fading memories of England's legendary World Cup victory.
Groundbreaking medical research from UCL and University College London Hospitals has successfully lowered levels of the toxic protein that causes Huntington's disease using an innovative genetic therapy injected into the spinal fluid.
Groundbreaking research reveals promising new approaches that could slow or even prevent Alzheimer's disease, marking a significant shift in the fight against dementia.